These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [CLINICAL AND ELECTROMYOGRAPHIC ANALYSIS OF EXTRAPYRAMIDAL SYMPTOMS CAUSED BY A NEUROLEPTICS AND THEIR RELATION TO THE TYPE OF DRUGS]. ZAKRZEWSKA F; SUJECKA-SZYMKIEWICZ H; GRABOWSKI K Neurol Neurochir Psychiatr Pol; 1965; 15():93-9. PubMed ID: 14348682 [No Abstract] [Full Text] [Related]
9. [Clinical classification of neuroleptics. Critical study and current prospects]. Kapsambelis V; Gekiere C; Ginestet D Encephale; 1990; 16(2):63-70. PubMed ID: 1972056 [TBL] [Abstract][Full Text] [Related]
10. [Disipal and the correction of parkinsonism induced by neuroleptics. (A critical review)]. MEURICE E Acta Neurol Psychiatr Belg; 1961 Jan; 61():47-66. PubMed ID: 13769933 [No Abstract] [Full Text] [Related]
12. [Treatment with neuroleptics is not dangerous for the patient. The risk of tardive dyskinesia is increased in overdosing]. Wiesel FA Lakartidningen; 1987 Sep; 84(40):3174-6. PubMed ID: 2890802 [No Abstract] [Full Text] [Related]
13. [Modern developments in the field of neuroleptics and thymoleptics and their meaning in the range of drugs of the DDR]. Hörig C Psychiatr Neurol Med Psychol Beih; 1975; 20-21():248-52. PubMed ID: 22887 [No Abstract] [Full Text] [Related]
14. [Comparative study of the antipsychotic action of certain neuroleptics modeled on LSD psychosis]. Krendal' FP; Kudrin AN Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):747-53. PubMed ID: 4146259 [No Abstract] [Full Text] [Related]
15. [PROBLEMS RAISED BY THE PROLONGED USE OF NEUROLEPTICS AND ANTIDEPRESSANTS. (SIGNIFICANCE OF THE STUDY OF NEUROMUSCULAR EXCITABILITY AND THE RATIO NAPL-KGB)]. POUGETOUX J; VIADER A; CAMPAGNOLLE A Ann Med Psychol (Paris); 1964 Jan; 122():61-90. PubMed ID: 14131351 [No Abstract] [Full Text] [Related]
16. [Antipsychotic agents: from phenothiazines to atypical neuroleptics of the second generation]. Raevskiĭ KS Eksp Klin Farmakol; 2003; 66(2):6-9. PubMed ID: 12962040 [TBL] [Abstract][Full Text] [Related]
17. [New antipsychotic agents: new paths of research on the notion of atypical agents]. Gosselin O; Di Scala G; Ribeyre JM; Kahn JP Encephale; 1996 Dec; 22 Spec No 6():3-6. PubMed ID: 9102317 [TBL] [Abstract][Full Text] [Related]
18. Psychopharmacology for neurologists. Dubovsky SL; Dubovsky AN Semin Neurol; 2009 Jul; 29(3):200-19. PubMed ID: 19551598 [TBL] [Abstract][Full Text] [Related]
19. Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Velligan DI; Lam F; Ereshefsky L; Miller AL Psychiatr Serv; 2003 May; 54(5):665-7. PubMed ID: 12719495 [No Abstract] [Full Text] [Related]
20. Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." Psychopharmacology (1980) 72:17-19. Angrist B; Rotrosen J; Gershon S Psychopharmacology (Berl); 2001 Nov; 158(3):219-21. PubMed ID: 11713609 [No Abstract] [Full Text] [Related] [Next] [New Search]